Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Abhigyan Satyam, Prabhjot Singh, Manoj Sharma, Amlesh Seth & Alpana Sharma. (2011) CYFRA 21-1: A potential molecular marker for noninvasive differential diagnosis of urothelial carcinoma of bladder. Biomarkers 16:5, pages 413-421.
Read now
Read now
S. Puthucode-Easwaran, R. Naik, R. Athavale, G. Handley, A. Lopes, K. Godfrey & M. Hatem. (2005) Comparison of pre-treatment CYFRA 21 – 1 and SCC-Antigen assay in primary cervical carcinoma – a preliminary report. Journal of Obstetrics and Gynaecology 25:5, pages 486-488.
Read now
Read now
Articles from other publishers (25)
Lukas L. Negrin, Gabriel Halat, Helmut Prosch, Michael Hüpfl, Stefan Hajdu & Thomas Heinz. (2017) Soluble Receptor for Advanced Glycation End Products Quantifies Lung Injury in Polytraumatized Patients. The Annals of Thoracic Surgery 103:5, pages 1587-1593.
Crossref
Crossref
Lukas L. Negrin, Gabriel Halat, Stephan Kettner, Markus Gregori, Robin Ristl, Stefan Hajdu & Thomas Heinz. (2017) Club cell protein 16 and cytokeratin fragment 21-1 as early predictors of pulmonary complications in polytraumatized patients with severe chest trauma. PLOS ONE 12:4, pages e0175303.
Crossref
Crossref
Zipu Yu, Guofei Zhang, Maoying Yang, Sai Zhang, Baiqin Zhao, Gang Shen & Ying Chai. (2016) Systematic review of CYFRA 21-1 as a prognostic indicator and its predictive correlation with clinicopathological features in Non-small Cell Lung Cancer: A meta-analysis. Oncotarget 8:3, pages 4043-4050.
Crossref
Crossref
Ondrej Fiala, Jindrich Finek, Tomas Buchler, Vit Martin Matejka, Lubos Holubec, Jana Kulhankova, Zbynek Bortlicek, Vaclav Liska & Ondrej Topolcan. (2015) The Association of Serum Carcinoembryonic Antigen, Carbohydrate Antigen 19-9, Thymidine Kinase, and Tissue Polypeptide Specific Antigen with Outcomes of Patients with Metastatic Colorectal Cancer Treated with Bevacizumab: a Retrospective Study. Targeted Oncology 10:4, pages 549-555.
Crossref
Crossref
Jean-Louis Campos-fernandes, Françoise Descotes, Jean Andre, Paul Perrin, Marian Devonec & Alain Ruffion. (2007) Intérêt des marqueurs urinaires dans le diagnostic et le suivi des tumeurs urothéliales de vessie. Progrès en Urologie 17:1, pages 23-34.
Crossref
Crossref
Daniel Fatela‐Cantillo, Antonio Fernández‐Suárez, Violeta Menéndez, Juan Antonio Galán & Xavier Filella. (2005) Low utility of CYFRA 21‐1 serum levels for diagnosis and follow‐up in bladder cancer patients. Journal of Clinical Laboratory Analysis 19:4, pages 167-171.
Crossref
Crossref
Oliver W. Hakenberg, Susanne Fuessel, Katja Richter, Michael Froehner, Sven Oehlschlaeger, Peter Rathert, Axel Meye & Manfred P. Wirth. (2004) Qualitative and quantitative assessment of urinary cytokeratin 8 and 18 fragments compared with voided urine cytology in diagnosis of bladder carcinoma. Urology 64:6, pages 1121-1126.
Crossref
Crossref
Ferah Armutçu, Remzi Altın, Ahmet Gürel, Levent Kart, Murat Unalacak & Arif H. Çımrın. (2004) Analysis of Carcinoembriyonic antigen, neurone specific enolase, cytokeratin 21-1 and ferritin levels in coal miners. Electronic Journal of General Medicine 1:1, pages 14-18.
Crossref
Crossref
Martina Tinzl & Michael Marberger. (2003) Urinary Markers for Detecting Bladder Cancer. EAU Update Series 1:2, pages 64-70.
Crossref
Crossref
Sharmila Upadhya, Subramanya Upadhya & D. M. Vasudevan. (2003) Tissue polypeptide specific antigen in the post therapeutic evaluation of patients with ovarian and colorectal cancer. Indian Journal of Clinical Biochemistry 18:1, pages 46-51.
Crossref
Crossref
Benjamin Nisman, Vivian Barak, Amos Shapiro, Dragan Golijanin, Tamar Peretz & Dov Pode. (2002) Evaluation of urine CYFRA 21‐1 for the detection of primary and recurrent bladder carcinoma. Cancer 94:11, pages 2914-2922.
Crossref
Crossref
Marta S�nchez-Carbayo, Manuel Urrutia, Jose M. Gonz�lez de Buitrago & Juan A. Navajo. (2001) Utility of serial urinary tumor markers to individualize intervals between cystoscopies in the monitoring of patients with bladder carcinoma. Cancer 92:11, pages 2820-2828.
Crossref
Crossref
M. S??NCHEZ-CARBAYO, M. URRUTIA, J. M. SILVA, R. ROMAN??J. M. GONZ??LEZ DE BUITRAGO & J. A. NAVAJO. (2001) COMPARATIVE PREDICTIVE VALUES OF URINARY CYTOLOGY, URINARY BLADDER CANCER ANTIGEN, CYFRA 21-1 AND NMP22 FOR EVALUATING SYMPTOMATIC PATIENTS AT RISK FOR BLADDER CANCER. The Journal of Urology, pages 1462-1467.
Crossref
Crossref
M. SÁNCHEZ-CARBAYO, M. URRUTIA, J.M. SILVA, R. ROMANÍ, J.M. GONZÁLEZ DE BUITRAGO & J.A. NAVAJO. (2001) COMPARATIVE PREDICTIVE VALUES OF URINARY CYTOLOGY, URINARY BLADDER CANCER ANTIGEN, CYFRA 21-1 AND NMP22 FOR EVALUATING SYMPTOMATIC PATIENTS AT RISK FOR BLADDER CANCER. Journal of Urology 165:5, pages 1462-1467.
Crossref
Crossref
Marta Sánchez-Carbayo, Manuel Urrutia, Juan Miguel Silva, Ramón Romaní, Javier García, Francisco Alférez, José Manuel González deBuitrago & Juan Alejandro Navajo. (2000) Urinary tissue polypeptide-specific antigen for the diagnosis of bladder cancer. Urology 55:4, pages 526-532.
Crossref
Crossref
Marta Sánchez-Carbayo, Manuel Urrutia, María Luisa Hernández-Cerceño, José Manuel González de Buitrago & José Alejandro Navajo. (2000) Citoqueratinas (UBC y CYFRA 21-1) y proteínas de la matriz nuclear (NMP22) como marcadores tumorales en la orina en el diagnóstico del cáncer vesical. Medicina Clínica 114:10, pages 361-366.
Crossref
Crossref
MARTA SÁNCHEZ-CARBAYO, ENRIQUE HERRERO, JULIÁN MEGÍAS, ANTONIO MIRA & FEDERICO SORIA. (1999) COMPARATIVE SENSITIVITY OF URINARY CYFRA 21-1, URINARY BLADDER CANCER ANTIGEN, TISSUE POLYPEPTIDE ANTIGEN AND NMP22 TO DETECT BLADDER CANCER. Journal of Urology 162:6, pages 1951-1956.
Crossref
Crossref
Marta Sánchez-Carbayo, Antonia Espasa, Virtudes Chinchilla, Enrique Herrero, Julián Megías, Antonio Mira & Federico Soria. (1999) New Electrochemiluminescent Immunoassay for the Determination of CYFRA 21-1: Analytical Evaluation and Clinical Diagnostic Performance in Urine Samples of Patients with Bladder Cancer. Clinical Chemistry 45:11, pages 1944-1953.
Crossref
Crossref
Marta Sánchez-Carbayo, Enrique Herrero, Julián Megías, Antonio Mira & Federico Soria. (1999) Initial evaluation of the new urinary bladder cancer rapid test in the detection of transitional cell carcinoma of the bladder. Urology 54:4, pages 656-661.
Crossref
Crossref
MARTA SANCHEZ-CARBAYO, ENRIQUE HERRERO, JULIAN MEGIAS, ANTONIO MIRA, ANTONIA ESPASA, VIRTUDES CHINCHILLA & FEDERICO SORIA. (1999) INITIAL EVALUATION OF THE DIAGNOSTIC PERFORMANCE OF THE NEW URINARY BLADDER CANCER ANTIGEN TEST AS A TUMOR MARKER FOR TRANSITIONAL CELL CARCINOMA OF THE BLADDER. The Journal of Urology, pages 1110-1115.
Crossref
Crossref
MARTA SANCHEZ-CARBAYO, ENRIQUE HERRERO, JULIAN MEGIAS, ANTONIO MIRA, ANTONIA ESPASA, VIRTUDES CHINCHILLA & FEDERICO SORIA. (1999) INITIAL EVALUATION OF THE DIAGNOSTIC PERFORMANCE OF THE NEW URINARY BLADDER CANCER ANTIGEN TEST AS A TUMOR MARKER FOR TRANSITIONAL CELL CARCINOMA OF THE BLADDER. Journal of Urology 161:4, pages 1110-1115.
Crossref
Crossref
P Ramon, JL Cazin, P Gosselin, C Fournier, B Boniface & JJ Lafitte. (1999) Intérêt du Cyfra 21-1 dans le cancer du poumon. Immuno-analyse & Biologie Spécialisée 14:1, pages 52-61.
Crossref
Crossref
Benjamin Nisman, Joel Lafair, Norman Heching, Olga Lyass, Mario Baras, Tamar Peretz & Vivian Barak. (1998) Evaluation of tissue polypeptide specific antigen, CYFRA 21-1, and carcinoembryonic antigen in nonsmall cell lung carcinoma. Cancer 82:10, pages 1850-1859.
Crossref
Crossref
M.P. Coulhon, K Abdelmalek & G Ternat. (1997) Cyfra 21-1 et tumeurs épidermoïdes des voies aérodigestives supérieures. Immuno-analyse & Biologie Spécialisée 12:6, pages 331-341.
Crossref
Crossref
Pierre M. Valdiguié, Eric Rogari, Joël X. Corberand & Bernard Boneu. (1996) The Performance of the Knowledge-Based System VALAB Revisited: An Evaluation after Five Years. cclm 34:4, pages 371-386.
Crossref
Crossref